Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study

The Medical Treatment of Obsessive-Compulsive Disorder and Anxiety

(2016) Borwin Bandelow   CNS SPECTRUMS

Recent Advances in Understanding and Treating Social Anxiety Disorder

(2015) Herman G. M. Westenberg   CNS SPECTRUMS

Pregabalin-Induced Hepatotoxicity

(2011) Juan Moll Sendra et al.   ANNALS OF PHARMACOTHERAPY

Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice

(2011) J. Bobes et al.   EUROPEAN PSYCHIATRY

Is There a Recreational Misuse Potential for Pregabalin Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data

(2011) Fabrizio Schifano et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Pregabalin in the Treatment of Alcohol and Benzodiazepines Dependence

(2010) Panagiotis Oulis et al.   CNS Neuroscience & Therapeutics

A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system

(2010) Sofie Schwan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome

(2010) M. Di Nicola et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Possible heart failure exacerbation associated with pregabalin: case discussion and literature review

(2010) Robert Lee Page et al.   Journal of Cardiovascular Medicine

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

(2010) Howard N. Bockbrader et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Modeling Dropout From Adverse Event Data: Impact of Dosing Regimens Across Pregabalin Trials in the Treatment of Generalized Anxiety Disorder

(2010) Bojan Lalovic et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Augmentation With Pregabalin in Schizophrenia

(2010) Susanne Englisch et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Slow vs standard up-titration of paroxetine in the treatment of panic disorder: A prospective randomized trial

(2010) Massimiliano Buoli et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Adjunctive Pregabalin to Quetiapine in Acute Mania

(2009) Panagiotis Oulis et al.   CLINICAL NEUROPHARMACOLOGY

Novel approaches to treatment of generalized anxiety disorder

(2009) Christer Allgulander   CURRENT OPINION IN PSYCHIATRY

Severe and disabling constipation: An adverse effect of pregabalin

(2009) Jordan T. Kamel et al.   EPILEPSIA

Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures

(2009) R. Eugene Ramsay et al.   EPILEPSIA

Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy

(2009) Bernardo Dell'Osso et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study

(2009) Alfredo Carlo Altamura et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder

(2009) R. Bruce Lydiard et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder

(2009) Bill Frame et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial

(2009) G. Martinotti et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pregabalin augmentation to antidepressants in patients with major depressive disorder

(2009) Chi-Un Pae   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective

(2009) David M. Marks et al.   Psychiatry Investigation

Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effect

(2008) Joseph Zohar et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies

(2008) Dan J. Stein et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pregabalin in the discontinuation of long-term benzodiazepines' use

(2008) Panagiotis Oulis et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study

(2008) Chi-Un Pae et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY